Redwood City, CA, United States of America

Stephan Jenne

This inventor holds 1 USPTO granted patent. Top assignee: Innovatus Life Sciences Lending Fund I, LP, as Collateral Agent. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Stephan Jenne. Retrieved from https://idiyas.com/inventor/stephan-jenne-crdz5iwu

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 14.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Stephan Jenne

Introduction

Stephan Jenne is an accomplished inventor based in Redwood City, CA. He has made significant contributions to the field of biochemistry, particularly with his work on penicillin-G acylases. His innovative approach has led to the development of a patent that showcases his expertise and dedication to advancing scientific knowledge.

Latest Patents

Stephan Jenne holds a patent for PENICILLIN-G ACYLASES. This invention highlights his ability to create solutions that can have a substantial impact on pharmaceutical applications. He has 1 patent to his name, reflecting his commitment to innovation in the industry.

Career Highlights

Currently, Stephan Jenne works at Innovatus Life Sciences Lending Fund I, LP, where he serves as a Collateral Agent. His role in this organization allows him to leverage his expertise in life sciences and contribute to the growth of innovative projects within the sector.

Collaborations

Throughout his career, Stephan has collaborated with notable professionals, including Rama Voladri and Christopher Michael Micklitsch. These partnerships have enabled him to expand his knowledge and enhance the impact of his inventions.

Conclusion

Stephan Jenne's contributions to the field of biochemistry through his patent on penicillin-G acylases exemplify his innovative spirit and dedication to advancing science. His work continues to inspire future developments in the pharmaceutical industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…